NZ528651A - Glycosylated interferon gamma polypeptide variants - Google Patents
Glycosylated interferon gamma polypeptide variantsInfo
- Publication number
- NZ528651A NZ528651A NZ528651A NZ52865102A NZ528651A NZ 528651 A NZ528651 A NZ 528651A NZ 528651 A NZ528651 A NZ 528651A NZ 52865102 A NZ52865102 A NZ 52865102A NZ 528651 A NZ528651 A NZ 528651A
- Authority
- NZ
- New Zealand
- Prior art keywords
- polypeptide variant
- seq
- ifng
- polypeptide
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100579 | 2001-04-06 | ||
| DKPA200100714 | 2001-05-07 | ||
| DKPA200200198 | 2002-02-11 | ||
| PCT/DK2002/000226 WO2002081507A2 (fr) | 2001-04-06 | 2002-04-04 | Variantes polypeptidiques a interferon gamma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ528651A true NZ528651A (en) | 2006-06-30 |
Family
ID=27222504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ528651A NZ528651A (en) | 2001-04-06 | 2002-04-04 | Glycosylated interferon gamma polypeptide variants |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1412382A2 (fr) |
| JP (1) | JP2005518183A (fr) |
| KR (1) | KR20030094336A (fr) |
| CN (1) | CN1257186C (fr) |
| BG (1) | BG108256A (fr) |
| BR (1) | BR0208596A (fr) |
| CA (1) | CA2443277A1 (fr) |
| HK (1) | HK1069834A1 (fr) |
| HU (1) | HUP0303645A3 (fr) |
| IL (1) | IL157896A0 (fr) |
| MX (1) | MXPA03009082A (fr) |
| NO (1) | NO20034432L (fr) |
| NZ (1) | NZ528651A (fr) |
| PL (1) | PL366705A1 (fr) |
| WO (1) | WO2002081507A2 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070172446A1 (en) | 2003-05-16 | 2007-07-26 | Intermune, Inc. | Synthetic chemokine receptor ligands and methods of use thereof |
| JP4707327B2 (ja) * | 2004-01-27 | 2011-06-22 | 旭化成ファーマ株式会社 | ポリペプタイド類の吸着防止剤 |
| CA2576030A1 (fr) * | 2004-08-09 | 2006-02-23 | Alios Biopharma Inc. | Variants de polypeptides synthetiques hyperglycosyles resistants a la protease, formulations orales et leurs procedes d'utilisation |
| US7597884B2 (en) * | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| CN103550757A (zh) * | 2005-09-20 | 2014-02-05 | 纽约大学 | 用干扰素治疗肺病的方法 |
| US7625555B2 (en) | 2007-06-18 | 2009-12-01 | Novagen Holding Corporation | Recombinant human interferon-like proteins |
| JP5769142B2 (ja) * | 2007-09-04 | 2015-08-26 | 独立行政法人酒類総合研究所 | ピヒア属酵母において異種タンパク質を高分泌させる方法 |
| EP2039764A1 (fr) * | 2007-09-19 | 2009-03-25 | Pevion Biotech AG | Protéinase aspartyl à sécrétoire tronqué 2 |
| BG66517B1 (bg) | 2008-04-08 | 2016-02-29 | Tigo Gmbh | Супресор на ендогенния човешки гама - интерферон |
| RU2446821C2 (ru) * | 2010-07-15 | 2012-04-10 | Олег Ильич Эпштейн | Лекарственное средство для лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способ лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями |
| GB201621728D0 (en) | 2016-12-20 | 2017-02-01 | Ucb Biopharma Sprl | Methods |
| BG67190B1 (bg) | 2017-03-29 | 2020-11-16 | Tigo Gmbh | Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон |
| WO2023182947A1 (fr) * | 2022-03-22 | 2023-09-28 | Chiang Mai University | Protéine modifiée d'interféron gamma et son utilisation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9203641A (es) * | 1983-12-16 | 1992-07-01 | Genentech Inc | Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion. |
| BG52073B2 (en) * | 1990-01-24 | 1996-04-30 | Inst Molekuljarna Biolog | Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine |
| DE4036856C1 (fr) * | 1990-11-19 | 1992-05-27 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De |
-
2002
- 2002-04-04 MX MXPA03009082A patent/MXPA03009082A/es not_active Application Discontinuation
- 2002-04-04 NZ NZ528651A patent/NZ528651A/en unknown
- 2002-04-04 HU HU0303645A patent/HUP0303645A3/hu unknown
- 2002-04-04 PL PL02366705A patent/PL366705A1/xx not_active Application Discontinuation
- 2002-04-04 CA CA002443277A patent/CA2443277A1/fr not_active Abandoned
- 2002-04-04 BR BR0208596-8A patent/BR0208596A/pt not_active IP Right Cessation
- 2002-04-04 WO PCT/DK2002/000226 patent/WO2002081507A2/fr active Application Filing
- 2002-04-04 IL IL15789602A patent/IL157896A0/xx unknown
- 2002-04-04 JP JP2002579493A patent/JP2005518183A/ja active Pending
- 2002-04-04 CN CNB028078918A patent/CN1257186C/zh not_active Expired - Fee Related
- 2002-04-04 EP EP02722021A patent/EP1412382A2/fr not_active Withdrawn
- 2002-04-04 KR KR10-2003-7013263A patent/KR20030094336A/ko not_active Application Discontinuation
-
2003
- 2003-10-03 NO NO20034432A patent/NO20034432L/no not_active Application Discontinuation
- 2003-10-10 BG BG108256A patent/BG108256A/bg unknown
-
2005
- 2005-03-15 HK HK05102256A patent/HK1069834A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20034432L (no) | 2003-10-29 |
| JP2005518183A (ja) | 2005-06-23 |
| CN1537117A (zh) | 2004-10-13 |
| HUP0303645A2 (hu) | 2004-01-28 |
| KR20030094336A (ko) | 2003-12-11 |
| PL366705A1 (en) | 2005-02-07 |
| HK1069834A1 (en) | 2005-06-03 |
| EP1412382A2 (fr) | 2004-04-28 |
| WO2002081507A2 (fr) | 2002-10-17 |
| IL157896A0 (en) | 2004-03-28 |
| BR0208596A (pt) | 2004-03-09 |
| WO2002081507A3 (fr) | 2004-02-12 |
| HUP0303645A3 (en) | 2005-12-28 |
| CN1257186C (zh) | 2006-05-24 |
| CA2443277A1 (fr) | 2002-10-17 |
| NO20034432D0 (no) | 2003-10-03 |
| BG108256A (bg) | 2004-12-30 |
| MXPA03009082A (es) | 2004-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7419805B2 (en) | Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression | |
| US7504237B2 (en) | Polynucleotides encoding interferon gamma polypeptides | |
| WO2002074806A2 (fr) | Nouvelles molecules de type interferon beta | |
| US7390638B2 (en) | S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants | |
| WO2001058950A1 (fr) | Interleukine-10 amelioree | |
| US7230081B1 (en) | Interferon gamma conjugates | |
| NZ528651A (en) | Glycosylated interferon gamma polypeptide variants | |
| US7524931B2 (en) | Full-length interferon gamma polypeptide variants | |
| AU2002252971B2 (en) | Interferon gamma polypeptide variants | |
| RU2268749C2 (ru) | КОНЪЮГАТЫ γ-ИНТЕРФЕРОНА | |
| RU2296130C2 (ru) | Варианты полипептида гамма-интерферона | |
| AU782635B2 (en) | Interferon gamma conjugates | |
| ZA200308376B (en) | Interferon gamma polypeptide variants. | |
| AU2002252971A1 (en) | Interferon gamma polypeptide variants | |
| CZ20033016A3 (cs) | Varianty polpeptidu interferonu gamma | |
| AU2002235727A1 (en) | New interferon beta-like molecules | |
| ZA200303964B (en) | New interferon beta-like molecules. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| PSEA | Patent sealed |